Impact of Madopar and Artane on depression in Parkinson's disease in a rat model

LI Jia-zhen,LIU Yi-ming,WU Lin,XIANG Yuan-yuan,ZHANG Yang,CHEN Si,REN Nan-nan
2011-01-01
Abstract:Objective To study the behavior of rats and hydroxytryptamine(5-HT) expression in their brain,and to analyze the impact of drug therapy on the depression in Parkinson′s disease.Methods Adult male Wistar rats were randomly divided into a blank group and an experimental group,each of 15.For another 90 rats,a Parkinson′s disease model was established for 55,and 45 were taken.For these,3 groups were formed: a PD group,a Madopar group and an Artane group,each of 15.Behavior and sucrose consumption were monitored as means to evaluate the rats′ depression.Expression of 5-HT was examined by immunohistochemistry.Results In body weight,rats in the PD group,Madopar group and Artane group were all lighter than both the blank and experimental groups(P<0.05).In sucrose consumption,the Madopar group and the Artane group were both lower than the PD group,and all these three groups were lower than the blank and experimental groups(P<0.05).Counts for neurons in the hippocampus and frontal lobe,as shown by 5-HT immunohistochemistry,in the Madopar group were lower than all other groups(P<0.05). Conclusion Depression was observed in PD model rats,and Madopar and Artane can aggravate this symptom.Administration of Madopar lowered 5-HT expression in the hippocampus and frontal lobe of the brain,which may contribute to the development of depression.
What problem does this paper attempt to address?